Latest news Olena Yakobchuk/Shutterstock.comThe Liver Meeting 2021: CoronavirusCOVID-19 vaccine protection is ‘lower and slower’ in people with cirrhosis. The Liver Meeting 2021: Hepatitis C eliminationHepatitis C treatment in US declined from 2015 to 2020. PexelsThe Liver Meeting 2021: CoronavirusTreatment for hepatitis B and C fell in 2020 due to COVID-19, global survey finds. infohep news New Three-drug regimen plus ribavirin cures the hardest-to-treat hepatitis C patients Keith Alcorn / 1 hour ago People who have experienced failure of multiple courses of direct-acting antiviral treatment can be cured of hepatitis C with a combination of three direct-acting antivirals plus ribavirin, a review of heavily treatment-experienced patients ... New Advanced fibrosis in people with NAFLD increases the risk of liver complications Keith Alcorn / 5 hours ago Advanced liver fibrosis in people with non-alcoholic fatty liver disease (NAFLD) was associated with an increased risk of liver-related complications, a prospective study in the United States has found. Fat accumulation in the ... View all infohep news Editors' picks from other sources ERN Rare Liver statement on SARS-CoV-2 booster vaccinations European Reference Network on Hepatological Diseases / 11 November 2021 Hepatitis C and Tuberculosis Long-Acting Medicines: Analysis of Patenting Trends and Implications for Access Treatment Action Group / 04 November 2021 Australia: Sustained investment is needed to eliminate hepatitis C by 2030 Burnet Institute / 04 November 2021 View all news from other sources Conference news More conference news Noticeboard ILC 2016 webinar: watch again More noticeboard posts Email updates Sign up for our monthly bulletins Sign up today Other pages in this section Latest news All the news Conference news Noticeboard Email bulletins News feeds